Literature DB >> 27085646

Age-mediated changes in the gastrointestinal tract.

Hamid A Merchant1, Fang Liu2, Mine Orlu Gul3, Abdul W Basit4.   

Abstract

Physiological functions of the two extreme ends of the age spectrum, children (<18 y old) and older adults (aged 65 y and over), differ from healthy young adults. This consequently affects the pharmacokinetic profiles of administered drugs, which, in turn, impacts upon clinical practice and drug therapy. The gastrointestinal milieu acts as a distinct and vital organ regulating the dissolution, absorption and metabolism of orally ingested drugs. Age-mediated alteration in the physiology and function of the gut can reshape the pharmacokinetics of certain drugs. However, our understanding of this topic is limited. This article references the gut physiology of healthy adults to capture the available evidence in the literature on the extent and nature of the changes in childhood and older age. The gut, as an organ, is examined with regards to the effect of age on luminal fluid, microbiota, transit and motility, and the intestinal mucosa. Whilst drastic developmental changes were observed in certain aspects of the gastrointestinal environment, the examination reveals significant gaps in our knowledge in the physiology and function of the developing or ageing gut. The revelation of the unknown paves the way towards a better characterization of the human gastrointestinal tract for optimized drug therapy in children and older adults.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Aging; Bioavailability; Gastrointestinal tract; Geriatrics; Paediatrics; Personalised medicine

Mesh:

Substances:

Year:  2016        PMID: 27085646     DOI: 10.1016/j.ijpharm.2016.04.024

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

1.  Gastrointestinal function in dementia with Lewy bodies: a comparison with Parkinson disease.

Authors:  Hirokazu Doi; Ryuji Sakakibara; Masayuki Masuda; Fuyuki Tateno; Yosuke Aiba; Masahiko Kishi; Tomonori Yamanishi; Tatsuya Yamamoto; Katsuyoshi Matsuoka
Journal:  Clin Auton Res       Date:  2019-02-11       Impact factor: 4.435

Review 2.  Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling.

Authors:  Gaëlle Magliocco; Frédérique Rodieux; Jules Desmeules; Caroline Flora Samer; Youssef Daali
Journal:  Pediatr Res       Date:  2019-10-10       Impact factor: 3.756

3.  Alleviating the Influence of Circadian Rhythms and Drug Properties to the Release of Paliperidone Gel Matrix Tablets with Compression Coating Technology and Microenvironment Shaping.

Authors:  Zherui Zhang; Shumin Chen; Man Wen; Haibing He; Yu Zhang; Tian Yin; Jingxin Gou; Xing Tang
Journal:  AAPS PharmSciTech       Date:  2022-08-16       Impact factor: 4.026

Review 4.  The Microbiome and Prostate Cancer Risk.

Authors:  Karen M Wheeler; Michael A Liss
Journal:  Curr Urol Rep       Date:  2019-09-07       Impact factor: 3.092

5.  Are We Using Slow-Acting Symptomatic Chondroprotective Drugs Conscious Enough?

Authors:  Seyit Ali Gumustas; Kadir Oznam; Cagri Ata Mutlu; Yasin Emre Kaya; Ibrahim Yilmaz; Mehmet Isyar; Aliye Yıldırım Guzelant; Olcay Guler; Semih Akkaya; Mahir Mahirogullari
Journal:  Open Orthop J       Date:  2017-05-31

6.  Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2-12 years.

Authors:  Jessica D Schulz; Jean T Coulibaly; Christian Schindler; David Wimmersberger; Jennifer Keiser
Journal:  J Antimicrob Chemother       Date:  2019-06-01       Impact factor: 5.790

Review 7.  Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa.

Authors:  Pushpa Pandiyan; Natarajan Bhaskaran; Mangge Zou; Elizabeth Schneider; Sangeetha Jayaraman; Jochen Huehn
Journal:  Front Immunol       Date:  2019-03-08       Impact factor: 7.561

8.  Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In-silico study.

Authors:  Sapna Negi; Harpreet Singh; Anirban Mukhopadhyay
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

Review 9.  Review of antimicrobial use and considerations in the elderly population.

Authors:  Angela Giarratano; Samantha El Green; David P Nicolau
Journal:  Clin Interv Aging       Date:  2018-04-17       Impact factor: 4.458

10.  The TORC1 inhibitor Nprl2 protects age-related digestive function in Drosophila.

Authors:  Junmeng Xi; Jiadong Cai; Yang Cheng; Yuanyuan Fu; Wanhong Wei; Zhenbo Zhang; Ziheng Zhuang; Yue Hao; Mary A Lilly; Youheng Wei
Journal:  Aging (Albany NY)       Date:  2019-11-11       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.